News

February 11, 2018: TECHFIELDS HAS HAD A SUCCESSFUL PROTOCOL TF-TF0023-21 INVESTIGATOR MEETING

Date:2018-02-12View: 651

Techfields has had a successful Protocol TF-TF0023-21 investigator meeting in Dallas, Texas on February 9-10, 2018. The study title is:

A Phase 2, Multicenter, Randomized, Double-blind (within dose), Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray versus Placebo in Functional Improvement of Patients with Ischemic Strokes